Grand Hopital de Charleroi - Site des Viviers

Charleroi 6060

0 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Small Cell Lung Cancer (SCLC), Solid Tumors

Studies at this site

• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Stopped early
• A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC — Running, not enrolling